WallStSmart

Equinix Inc (EQIX)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 29% more annual revenue ($12.76B vs $9.90B). EQIX leads profitability with a 15.5% profit margin vs 12.1%. EQIX appears more attractively valued with a PEG of 3.28. WELL earns a higher WallStSmart Score of 57/100 (C).

EQIX

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 7.5Value: 2.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.55

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 6.3
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EQIXSignificantly Overvalued (-81.1%)

Margin of Safety

-81.1%

Fair Value

$583.22

Current Price

$1042.62

$459.40 premium

UndervaluedFair: $583.22Overvalued
WELLSignificantly Overvalued (-89.9%)

Margin of Safety

-89.9%

Fair Value

$124.92

Current Price

$236.92

$112.00 premium

UndervaluedFair: $124.92Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EQIX4 strengths · Avg: 8.3/10
Market CapQuality
$103.76B9/10

Large-cap with strong market position

Operating MarginProfitability
27.0%8/10

Strong operational efficiency at 27.0%

Revenue GrowthGrowth
16.7%8/10

16.7% revenue growth

EPS GrowthGrowth
28.8%8/10

Earnings expanding 28.8% YoY

WELL4 strengths · Avg: 9.3/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Market CapQuality
$166.86B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

Areas to Watch

EQIX4 concerns · Avg: 2.5/10
Debt/EquityHealth
1.633/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.282/10

Expensive relative to growth rate

P/E RatioValuation
66.2x2/10

Premium valuation, high expectations priced in

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.3%3/10

ROE of 3.3% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
103.4x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : EQIX

The strongest argument for EQIX centers on Market Cap, Operating Margin, Revenue Growth. Profitability is solid with margins at 15.5% and operating margin at 27.0%. Revenue growth of 16.7% demonstrates continued momentum.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Debt/Equity, Market Cap. Revenue growth of 39.1% demonstrates continued momentum.

Bear Case : EQIX

The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 66.2x leaves little room for execution misses. Debt-to-equity of 1.63 is elevated, increasing financial risk.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 103.4x leaves little room for execution misses.

Key Dynamics to Monitor

EQIX carries more volatility with a beta of 0.97 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

Monitor REIT - SPECIALTY industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WELL scores higher overall (57/100 vs 56/100) and 39.1% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Equinix Inc

REAL ESTATE · REIT - SPECIALTY · USA

Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?